Format

Send to

Choose Destination
Nutrients. 2018 Nov 21;10(11). pii: E1812. doi: 10.3390/nu10111812.

Expression of Selenoprotein Genes and Association with Selenium Status in Colorectal Adenoma and Colorectal Cancer.

Author information

1
Cancer Biology and Therapeutics Group, UCD Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland. david.hughes@ucd.ie.
2
Biomedical Centre, Medical and Teaching School Pilsen, Charles University in Prague, 323 00 Pilsen, Czech Republic. terez.kunicka@gmail.com.
3
Institute for Experimental Endocrinology, University Medical School Berlin, D-13353 Berlin, Germany. lutz.schomburg@charite.de.
4
Biomedical Centre, Medical and Teaching School Pilsen, Charles University in Prague, 323 00 Pilsen, Czech Republic. vena.liska@skaut.cz.
5
Teaching Hospital and Medical School, Charles University in Prague, 306 05 Pilsen, Czech Republic. vena.liska@skaut.cz.
6
Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland. n.swan@svuh.ie.
7
Biomedical Centre, Medical and Teaching School Pilsen, Charles University in Prague, 323 00 Pilsen, Czech Republic. pavel.soucek@szu.cz.
8
Teaching Hospital and Medical School, Charles University in Prague, 306 05 Pilsen, Czech Republic. pavel.soucek@szu.cz.

Abstract

Dietary selenium (Se) intake is essential for synthesizing selenoproteins that are important in countering oxidative and inflammatory processes linked to colorectal carcinogenesis. However, there is limited knowledge on the selenoprotein expression in colorectal adenoma (CRA) and colorectal cancer (CRC) patients, or the interaction with Se status levels. We studied the expression of seventeen Se pathway genes (including fifteen of the twenty-five human selenoproteins) in RNA extracted from disease-normal colorectal tissue pairs, in the discovery phase of sixty-two CRA/CRC patients from Ireland and a validation cohort of a hundred and five CRC patients from the Czech Republic. Differences in transcript levels between the disease and paired control mucosa were assessed by the Mann-Whitney U-test. GPX2 and TXNRD3 showed a higher expression and GPX3, SELENOP, SELENOS, and SEPHS2 exhibited a lower expression in the disease tissue from adenomas and both cancer groups (p-values from 0.023 to <0.001). In the Czech cohort, up-regulation of GPX1, SELENOH, and SOD2 and down-regulation of SELENBP1, SELENON, and SELENOK (p-values 0.036 to <0.001) was also observed. We further examined the correlation of gene expression with serum Se status (assessed by Se and selenoprotein P, SELENOP) in the Irish patients. While there were no significant correlations with both Se status markers, SELENOF, SELENOK, and TXNRD1 tumor tissue expression positively correlated with Se, while TXNRD2 and TXNRD3 negatively correlated with SELENOP. In an analysis restricted to the larger Czech CRC patient cohort, Cox regression showed no major association of transcript levels with patient survival, except for an association of higher SELENOF gene expression with both a lower disease-free and overall survival. Several selenoproteins were differentially expressed in the disease tissue compared to the normal tissue of both CRA and CRC patients. Altered selenoprotein expression may serve as a marker of functional Se status and colorectal adenoma to cancer progression.

KEYWORDS:

biomarkers; cancer risk; colorectal adenoma; colorectal cancer; colorectal neoplasm; gene expression; selenium (Se), selenoproteins; selenium status; selenoprotein P

PMID:
30469315
PMCID:
PMC6266908
DOI:
10.3390/nu10111812
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center